Cara TenenbaumJD/MBA

Crowell Health Solutions Consultant | JD/MBA
Crowell Health Solutions Consultant | JD/MBA

Overview

Cara is a Consultant for Crowell Health Solutions and a seasoned health policy expert, advocate, and writer with almost two decades of health policy experience. That includes experience in the patient advocacy field, having been the head of policy for a small non-profit focusing on women's health. There, she handled all advocacy, including appropriations, authorizing legislation, drafting testimony, presenting testimony, preparing regulatory comment letters and working with all operating divisions of HHS, as needed. Additionally, she functioned as spokesperson for the organization, appearing on national and international TV as well as in print. Cara was at the FDA for six years, working in both the Office of External Affairs in the Commissioner's Office and the Office of the Center Director in the Center for Devices and Radiological Health. There, Cara worked on issues at the intersection of policy, legislation and advocacy, helping further the Agency's agenda with patient and provider groups.

She has worked or volunteered in the pro-choice field off and on for 20 years, including being a clinic escort, volunteering with abortion funds, and doing patient counseling at an abortion clinic.

Cara has numerous legal publications, and provides off and on the record interviews to press.

She holds a JD and MBA from Case Western Reserve University and a BA in Economics from the University of Maryland, College Park.

Career & Education

|
    • Case Western Reserve University, JD/MBA
    • University of Maryland, College Park, B.A., Economics
    • Case Western Reserve University, JD/MBA
    • University of Maryland, College Park, B.A., Economics

Cara's Insights

Client Alert | 11 min read | 05.03.24

FDA Moves Forward on Laboratory Developed Tests while Stakeholders and Congress Weigh Next Steps

Digital health companies, investors, and other healthcare organizations should follow policy developments with a strategic lens towards their market opportunities for key potential growth and risk mitigation....

Cara's Insights

Client Alert | 11 min read | 05.03.24

FDA Moves Forward on Laboratory Developed Tests while Stakeholders and Congress Weigh Next Steps

Digital health companies, investors, and other healthcare organizations should follow policy developments with a strategic lens towards their market opportunities for key potential growth and risk mitigation....